Abstract CT200: IMpower130: Progression-free Survival (PFS) and Safety Analysis from a Randomized Phase 3 Study of Carboplatin + Nab-Paclitaxel (cnp) with or Without Atezolizumab As First-Line (1L) Therapy in Advanced Non-Squamous NSCLC
CANCER RESEARCH(2019)
关键词
Neuroprotective Strategies
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要